Anne J. Lexmond

9713, Av
Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I CFTR variants.

The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I CFTR variants.

Journal: The European respiratory journal

Published: July 18, 2025

Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.

Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.

Journal: Respiratory research

Published: September 17, 2018

Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma.

Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma.

Journal: BMC pulmonary medicine

Published: June 12, 2018

A novel method for studying airway hyperresponsiveness in allergic guinea pigs in vivo using the PreciseInhale system for delivery of dry powder aerosols.

A novel method for studying airway hyperresponsiveness in allergic guinea pigs in vivo using the PreciseInhale system for delivery of dry powder aerosols.

Journal: Drug delivery and translational research

Published: February 23, 2018

Realising the potential of various inhaled airway challenge agents through improved delivery to the lungs.

Realising the potential of various inhaled airway challenge agents through improved delivery to the lungs.

Journal: Pulmonary pharmacology & therapeutics

Published: December 20, 2017

Bronchial Provocation Testing Can Be Improved by Using Dry Powder Adenosine Instead of Nebulized Adenosine Monophosphate.

Bronchial Provocation Testing Can Be Improved by Using Dry Powder Adenosine Instead of Nebulized Adenosine Monophosphate.

Journal: American journal of respiratory and critical care medicine

Published: June 27, 2017

Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.

Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.

Journal: Respiratory medicine

Published: May 01, 2017

Targeting the small airways with dry powder adenosine: a challenging concept.

Targeting the small airways with dry powder adenosine: a challenging concept.

Journal: European clinical respiratory journal

Published: April 26, 2017

Prerequisites for a dry powder inhaler for children with cystic fibrosis.

Prerequisites for a dry powder inhaler for children with cystic fibrosis.

Journal: PloS one

Published: March 29, 2017

Drug Delivery Devices for Inhaled Medicines.

Drug Delivery Devices for Inhaled Medicines.

Journal: Handbook of experimental pharmacology

Published: November 05, 2016

Effect of inhaler design variables on paediatric use of dry powder inhalers.

Effect of inhaler design variables on paediatric use of dry powder inhalers.

Journal: PloS one

Published: March 27, 2014

Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjects.

Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjects.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: February 17, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026